[{"address1": "11 Hurley Street", "city": "Cambridge", "state": "MA", "zip": "02141", "country": "United States", "phone": "617 401 9000", "website": "https://www.editasmedicine.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 246, "companyOfficers": [{"maxAge": 1, "name": "Dr. Gilmore  O'Neill M.D.", "age": 61, "title": "President, CEO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 1116286, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Feng  Zhang Ph.D.", "title": "Co-Founder & Scientific Advisory Board Member", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. George McDonald Church Ph.D.", "age": 71, "title": "Co-Founder & Scientific Advisory Board Member", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy  Parison", "age": 39, "title": "Senior VP & CFO", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregory  Whitehead", "title": "Executive VP and Chief Technical & Quality Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Linda C. Burkly Ph.D.", "age": 67, "title": "Executive VP & Chief Scientific Officer", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 522442, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cristi  Barnett", "title": "Senior VP of Corporate Communications & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Damien  Grierson J.D.", "title": "Senior VP, General Counsel & Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Frank  Panaccio", "title": "Senior VP & Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Brieana  Buckley", "title": "Senior Vice President of Development and Program Leadership", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 5, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.81, "open": 1.79, "dayLow": 1.725, "dayHigh": 1.8, "regularMarketPreviousClose": 1.81, "regularMarketOpen": 1.79, "regularMarketDayLow": 1.725, "regularMarketDayHigh": 1.8, "payoutRatio": 0.0, "beta": 2.191, "forwardPE": -1.5655473, "volume": 1528576, "regularMarketVolume": 1528576, "averageVolume": 1691549, "averageVolume10days": 1338920, "averageDailyVolume10Day": 1338920, "bid": 1.76, "ask": 1.81, "bidSize": 3, "askSize": 6, "marketCap": 174737392, "fiftyTwoWeekLow": 0.91, "fiftyTwoWeekHigh": 4.537, "allTimeHigh": 99.95, "allTimeLow": 0.91, "priceToSalesTrailing12Months": 3.7672722, "fiftyDayAverage": 2.1059, "twoHundredDayAverage": 2.498075, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 28741402, "profitMargins": 0.0, "floatShares": 97264304, "sharesOutstanding": 97618660, "sharesShort": 11464526, "sharesShortPriorMonth": 11320572, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.1174, "heldPercentInsiders": 0.00518, "heldPercentInstitutions": 0.54396, "shortRatio": 6.02, "shortPercentOfFloat": 0.1177, "impliedSharesOutstanding": 97618660, "bookValue": 0.144, "priceToBook": 12.430556, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -199835008, "trailingEps": -2.35, "forwardEps": -1.14337, "enterpriseToRevenue": 0.62, "enterpriseToEbitda": -0.257, "52WeekChange": -0.099502504, "SandP52WeekChange": 0.14684999, "quoteType": "EQUITY", "currentPrice": 1.79, "targetHighPrice": 13.0, "targetLowPrice": 1.0, "targetMeanPrice": 5.42857, "targetMedianPrice": 5.0, "recommendationMean": 2.28571, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 165648000, "totalCashPerShare": 1.697, "ebitda": -112038000, "totalDebt": 19652000, "quickRatio": 2.813, "currentRatio": 2.864, "totalRevenue": 46383000, "debtToEquity": 146.079, "revenuePerShare": 0.545, "returnOnAssets": -0.28263, "returnOnEquity": -2.11368, "grossProfits": -64777000, "freeCashflow": -65967500, "operatingCashflow": -179616000, "revenueGrowth": 122.656, "grossMargins": -1.39657, "ebitdaMargins": -2.4155, "operatingMargins": -3.25441, "financialCurrency": "USD", "symbol": "EDIT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_252050056", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "epsTrailingTwelveMonths": -2.35, "epsForward": -1.14337, "epsCurrentYear": -1.93898, "priceEpsCurrentYear": -0.9231658, "fiftyDayAverageChange": -0.3159001, "fiftyDayAverageChangePercent": -0.15000716, "twoHundredDayAverageChange": -0.70807505, "twoHundredDayAverageChangePercent": -0.28344828, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1771634971, "regularMarketTime": 1771621201, "regularMarketChangePercent": -1.10497, "regularMarketPrice": 1.79, "shortName": "Editas Medicine, Inc.", "longName": "Editas Medicine, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1454509800000, "postMarketChangePercent": -3.3296087, "postMarketPrice": 1.7304, "postMarketChange": -0.059599996, "regularMarketChange": -0.02, "regularMarketDayRange": "1.725 - 1.8", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1691549, "fiftyTwoWeekLowChange": 0.87999994, "fiftyTwoWeekLowChangePercent": 0.96703285, "fiftyTwoWeekRange": "0.91 - 4.537", "fiftyTwoWeekHighChange": -2.7470002, "fiftyTwoWeekHighChangePercent": -0.6054662, "fiftyTwoWeekChangePercent": -9.950251, "earningsTimestampStart": 1773235800, "earningsTimestampEnd": 1773235800, "earningsCallTimestampStart": 1723032000, "earningsCallTimestampEnd": 1723032000, "isEarningsDateEstimate": true, "displayName": "Editas Medicine", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]